Form Approved
OMB No. 0935-0124
Exp. Date XX/XX/20XX
1.1 Date abstraction completed
_ _ / _ _ /_ _ _ _
1.2 Abstractor identification number
_ _ _ _ _ _ _ _ _
2.1 AHRQ Study identification number
_ _ _ _ _ - _ _ _ _
2 Medical record number/Patient control number
_ _ _ _ _ _ _ _ _
2.3 Date of birth
_ _ / _ _ / _ _ _ _
2.4 Gender
Male
Female
2.5 Date of admission
_ _ / _ _ / _ _ _ _
Date of discharge
3.1 Did the patient undergo an operation involving the abdomen or pelvis?
Yes
No
Critical documentation missing
If Q3.1= NO, explain the reason why this chart was most likely flagged for review in the TEXT BOX provided and END the abstraction.
|
|
3.2 Was pregnancy or a condition related to pregnancy the patient’s primary admitting diagnosis?
Yes
No
If Q3.2=Yes, explain the reason why this chart was most likely flagged for review in the TEXT BOX provided and END the abstraction.
|
|
Did the patient have a wound dehiscence that occurred during this hospitalization?
Yes
No
If Q3.3=No, explain the reason why this chart was most likely flagged for review in the TEXT BOX provided and END the abstraction.
|
|
3.4 Did the patient have any of the following immunosuppressive conditions on admission? Select all that apply.
.
|
yes |
no |
HIV/AIDS |
|
|
Severe malnutrition – (e.g., Kwashiorkor or nutritional marasmus ) |
|
|
Chronic kidney disease (e.g., end stage renal failure) |
|
|
Immunoglobulin deficiency – (e.g. selective IG deficiency) |
|
|
Transplant- any “ major” organ transplantation and complications |
|
|
Other immunodeficiency specified in appendix? of the PSI Technical Specifications–(e.g., Digeorges syndrome, Nezelofs syndrome or Wiscott-Aldrich syndrome) |
|
|
If the patient had any of the above immunosuppressive conditions, briefly explain why the chart was most likely flagged for review in the TEXT BOX provided below and then END the abstraction.
|
|
4.1 Did the patient have any of the following conditions as listed below at the time of admission? Select all that apply.
|
yes |
no |
Sickle cell disease |
|
|
Short gut syndrome |
|
|
Systemic steroids on admission |
|
|
If answered YES to systemic steroids on admission state the indication in the TEXT BOX below.
|
|
4.2 Height on admission:
[_ _ _ ._ _](cm) or [_ _] ft {[ _ ] inches
4.3 Weight on admission:
[_ _ _ ._ _](kg) or [_ _ _ ._ _ ] pounds(lbs)
5.1 How many operations involving the abdomen or pelvis occurred during this hospital stay?
1
2
3
4
5
More than 5
For each separate visit to the operating room photocopy pages 4- 7, answer Q 5.2- 5.12 Do only the MOST significant procedures that were performed in that particular trip to the operating room.
For each visit to the operating room complete pages 4-7 (Q5.2—5.12).
Visit# __
5.2 Specify the date and time of the procedure:
Date: _ _ / _ _ /_ _ _ _ Time: _ _ : _ _
5.3 State the primary procedure names(s) and associated ICD-9CM codes(s):
ICD-9-CM code - |
Look-up box for procedure names |
1. |
1. |
2. |
2. |
3. |
3. |
4. |
4. |
5. |
5. |
5.4 Using physician notes or operative notes, describe the indication for the procedure.
|
|
|
5.5 Indicate the type of incision used:
Extension of previous incision
Local right lower quadrant (e.g., McBurney or Rocky-Davis)
Midline vertical (partial or full extent)
Oblique flank (e.g., retroperitoneal approach)
Oblique iliac fossa (e.g., kidney transplant approach)
Paramedian vertical
Transverse subcostal
Transverse (rectus-transecting)
Transverse (rectus-sparing) (e.g.,Pfannenstiel)
No incision
Critical documentation missing
Other – describe in the text box below:
|
|
5.6 Did the procedure involve repair of a defect (or hole) in the abdominal wall fascia that existed prior to this procedure?
Yes → Answer Q5.7
No → SKIP to Q5.8
Critical documentation missing → SKIP to Q5.8
For each visit to the operating room complete pages 4-7 (Q5.2—5.12)
Visit# __
For patients that had a procedure that involved repair of defect or hole in the abdominal wall fascia, continue with questions 5.7, otherwise skip to Q5.8.
5.7a On what date was this defect in the abdominal wall fascia first identified?
_ _ /_ _ /_ _ _ _
5.7b Using the operative note, describe the dimensions and nature of the defect in the fascia in the text box provided.
|
|
5.7c Was the defect in the fascia associated with evisceration of the abdominal contents prior to this procedure?
Yes
No
Critical documentation missing
5.7d Using the physicians’ notes and operative notes, indicate all factors associated with the defect in the fascia. Check all that apply.
Yes = documentation indicated by the surgeon that this occurred
No = documentation indicated by the surgeon that this did not occur
Documentation insufficient = documentation insufficient to determine whether this occurred.
|
Yes |
No |
Documentation insufficient |
Breakage of suture material |
|
|
|
Unraveling of a tied suture |
|
|
|
Tearing of the fascia with necrosis of the fascia |
|
|
|
Tearing of the fascia without necrosis of the fascia |
|
|
|
Unintentional failure to close a defect in the fascia |
|
|
|
Intentional failure to close a defect in the fascia |
|
|
|
Infection of the abdominal or pelvic cavity or wall |
|
|
|
Other factors related to fascial defect (describe in text box below ). |
|
|
|
For each visit to the operating room complete pages 4-7 (Q5.2—5.12)
Visit# __
Other factors: |
|
5.8 Did the procedure involve repair of a defect (or hole) in the abdominal skin that existed prior to this procedure?
Yes → answer Q3.13
No → continue with Q3.14
Critical documentation missing →continue with Q3.14
If “Yes” to Q5.8, answer Q5.9, otherwise continue with Q5.10.
5.9a On what date was this defect in the abdominal skin first identified?
_ _ / _ _ /_ _ _ _
5.9b Did the operation involve a skin graft?
Yes
No
Critical documentation missing
5.9c Was any portion of the FASCIA closed with sutures during this visit to the operating room?
Yes → answer Q3.15
No → answer Q3.16
Critical documentation missing → answer Q3.16
If “Yes” to Q3.14, answer Q3.15; otherwise continue with Q3.16.
5.10a What suture size was used to close the fascia of the abdomen or pelvis? Suture size is listed from larger to smaller size in descending order. Check all that apply.
#2
#1
0
1.0
2.0
3.0
Other (describe) ______________________________________
For each visit to the operating room complete pages 4-7 (Q3.6-3.16)
Visit# __
Not specified
5.10b What was the primary suture type used to close the FASCIA of the abdomen or pelvis?
Silk
Vicryl
Polysorb
Dexon
PDS
Maxon
Prolene
Surgipro
Tevdek
Surgidac
TiCron
Other (describe)
Not specified
If more than one suture type was
used to close the FASCIA of the abdomen or pelvis, describe the other
suture type(s) in the textbox below.
2nd suture type:
|
3nd suture size:
|
5.10c Was the entire fascial defect closed during this visit to the operating room?
Yes
No
Critical documentation missing
5.11 Were retention sutures placed during this visit to the operating room?
Yes
No
Critical documentation missing
Section 6: Outcomes
6.1 Did evisceration of abdominal contents occur during this hospitalization?
Yes
No
Critical documentation missing
6.2 Was an abdominal or pelvic fascial defect or hernia left unrepaired during this hospitalization?
Yes
No
Critical documentation missing
6.3 Does the medical record suggest that the patient suffered any adverse effects or consequences from disruption of fascia that was closed during an abdominal or pelvic operation? Check all that apply.
Extended length of hospital stay
Infection
Residual disability or impairment of normal function (at discharge)
Readmission within 30 days
Death
None or not specified
6.4 If there are special circumstances or comments related to this case that you feel are important that were not captured in the survey, please state in the TEXT BOX [Limit 200 characters].
________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________
Page
File Type | application/msword |
File Title | Nov 9, 2006 Abstraction Instrument for Validation of selected AHRQ Quality Indicators – Post-operative Wound Dehiscence (PSI 14) |
Author | rbaron |
Last Modified By | wcarroll |
File Modified | 2008-06-27 |
File Created | 2008-05-22 |